Medtech grants
Explore grants for medtech companies. This directory brings together funding for medical devices, diagnostics, digital health, surgical technology and clinical validation, from health research agencies, national innovation programs, disease foundations and hospital-led challenges.
Showing 217-240 of 2,426 grants
One-Step, Rapid, Low-Cost Definitive Drug Testing at the Point of Need Challenge
🇺🇸NIDA · United States
Pays up to $600,000 in prizes to teams building rapid, low-cost drug-testing device prototypes.
EIC Accelerator — Short Proposal
🇮🇱ISERD · Israel
Supports small and medium firms in early-stage deep technologies through public proposals and commercialization mentoring.
FFG Austrian Life Sciences
🇦🇹FFG · Austria
Supports Austrian life-science innovation in digital health, drug development, and medical technologies.
WEAVE-UNISONO
🇵🇱NCN · Poland
Funds bilateral and trilateral Polish research collaborations through lead-agency international partnerships.
Estrdad Government Fee Refund Initiative
🇸🇦Monsha'at · Saudi Arabia
Funds Saudi startups by refunding selected government fees and patent-registration costs.
Oligonucleotide Toxicity (OligoTox) Open Data Challenge
🇺🇸NCATS · United States
Pays cash prizes for public datasets that help predict oligonucleotide drug toxicity in human cells.
VFF Early Stage Financing
🇳🇱RVO · Netherlands
Supports early-stage venture financing that helps start-ups turn prototypes into scalable, innovation-driven products.
ARPA-H SBIR/STTR
🇺🇸ARPA-H · United States
Funds United States small businesses bridging health and neuroscience technologies from feasibility into advanced development.
NIH SBIR Direct-to-Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses moving directly into major development when early biomedical feasibility is already established.
NIH SBIR Fast-Track (Omnibus)
🇺🇸NIH · United States
Supports United States small businesses with streamlined biomedical pathways from feasibility to continued development.
NIH SBIR Phase I (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses advancing biomedical and behavioral-health innovations through early technical validation.
NIH SBIR Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses advancing validated biomedical innovations through substantial full development execution.
NIH STTR Phase I (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses partnering with nonprofit research institutions to validate biomedical ideas.
NIH STTR Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small-business and research-partner teams advancing biomedical projects already proven in early studies.
Broad Call for Interventions Improving Outcomes in Adults with Faecal Incontinence
🇬🇧NIHR · United Kingdom
Funds UK trials evaluating clinical and cost-effectiveness of faecal-incontinence care.
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions
🇺🇸NIH · United States
Funds small clinical-trial research at undergraduate-focused colleges that get under $6 million a year from NIH.
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems
NIH · United States
Funds a company and an academic group working as one team to turn an imaging, spectroscopy or data-science advance into something usable in the clinic.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01)
NIH · United States
Funds work on how GLP-1 and related drugs change cancer risk — raising it for some cancers, lowering it for others.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21)
NIH · United States
Funds smaller, higher-risk work on how GLP-1 and related drugs change cancer risk. No clinical trial in this version.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis
NIH · United States
Funds a Phase 0, I or II cancer trial that the investigator designed, inside one of six named National Cancer Institute programme areas.
NHLBI Clinical Trial Pilot Studies
🇺🇸NIH · United States
Funds pilot work that is both necessary and sufficient to plan a later phase II, III or IV trial — with no further studies needed in between.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders
NIH · United States
Funds Phase I trials for heart, lung, blood and sleep disorders — and pays for the final preclinical work needed to start one.
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
🇺🇸NIH · United States
Funds an investigator's own phase I trial in heart, lung, blood or sleep disease — with every regulatory approval already in hand at award.
Personal Health Informatics for Delivering Actionable Insights to Individuals
NIH · United States
Funds informatics tools that take a person's own health data and hand back a risk assessment they can understand and do something about.